Study evaluating Symptom and Distress screening tools in initiating early supportive care in cancer patients treated with curative radiation therapy
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2022/01/039478
- Lead Sponsor
- Debnarayan Dutta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All consecutive patients diagnosed with non metastatic cancer of any site planned for treatment with radical intent radiation therapy
Exclusion Criteria
Previous radiation therapy
Patients planned for treatment with 10 fractions or less
Patients with multiple distant metastases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine mean change in Total ESAS-r score from baseline to RT completion or follow up visit (3 month)Timepoint: 3 month after RT completion
- Secondary Outcome Measures
Name Time Method -To determine mean change in QOL scores (FACT- G , TOI scores) from baseline to 1 or 3 months post RTTimepoint: 3 months;-To determine mean timing of maximum distress from baseline to 6 months post RTTimepoint: 6 months;-To determine most frequent distressing symptomTimepoint: End of treatment;-To determine proportion of patients with moderate to severe distress during radiation therapyTimepoint: End of treatment;-To determine the mean change in Anxiety & depression score from baseline to 1 / 3 months post RTTimepoint: 3 months;-To determine the mean change in symptom score because of supportive care using ESAS toolTimepoint: 6 months;-To determine the proportion of asymptomatic patients on radiation therapy requiring supportive care based on distress score changesTimepoint: End of treatment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie symptom and distress screening in early supportive care for curative radiation therapy patients?
How does early supportive care via symptom screening compare to standard care in curative radiation therapy for neoplasms?
Are there specific biomarkers that correlate with distress levels in cancer patients undergoing radiation therapy?
What adverse events are commonly associated with curative radiation therapy and how does early supportive care mitigate them?
What are the current advancements in supportive care strategies for C00-D49 neoplasms alongside radiation therapy?